Patrizia Tempora
Rome, 00146, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Discovery of a new selective ERAP1 inhibitor for Hedgehog-dependent cancer treatment.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 11, 2025
Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 24, 2024
Two bullets in the gun: combining immunotherapy with chemotherapy to defeat neuroblastoma by targeting adrenergic-mesenchymal plasticity.
Journal: Frontiers in immunology
Published: July 28, 2023
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 09, 2022
Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy.
Journal: Frontiers in immunology
Published: May 19, 2022
ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function.
Journal: Frontiers in immunology
Published: September 16, 2021
ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19?
Journal: International journal of molecular sciences
Published: December 29, 2020
Dendritic Cells: Behind the Scenes of T-Cell Infiltration into the Tumor Microenvironment.
Journal: Cancers
Published: December 27, 2020
Impact of Natural Occurring ERAP1 Single Nucleotide Polymorphisms within miRNA-Binding Sites on HCMV Infection.
Journal: International journal of molecular sciences
Published: July 22, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026